Aline Dietzig

发表

Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib.

W. Pao, B. Kuhn, A. Kuglstatter, 2022, Journal of medicinal chemistry.

Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells

C. Klein, R. Kontermann, A. Ducret, 2021, The Journal of Immunology.